Arcturus therapeutics to report first quarter financial results and provide corporate update on may 8, 2024

San diego--(business wire)---- $arct #clinicaltrial--arcturus therapeutics holdings inc. (the “company”, “arcturus”, nasdaq: arct), a global messenger rna medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today announced that it will release its financial results for the quarter ended march 31, 2024 after the market close on wednesday, may 8 and will also host a conference call and webcast at 4:30 pm eastern time on may 8, 2024. arc.
ARCT Ratings Summary
ARCT Quant Ranking